Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 3Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Breast 2Thoracic 1Endocrine 1

Conditions

Breast Neoplasms 2Pituitary Neoplasms 1Lung Neoplasms 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × Supine Position × Clear all
NCT04584866 2025-04-29

PosESS

University Hospital, Basel, Switzerland

Phase NA Completed
54 enrolled
Endocrine

Pituitary Neoplasms

NCT06789276 2025-01-23

The Impact of Thoracic Paravertebral Nerve Block At Different Positions on Pain Relief in Patients Undergoing Single-Port Thoracoscopic Partial Lung Resection

Second Affiliated Hospital of Soochow University

Phase NA Not yet recruiting
200 enrolled
Thoracic

Lung Neoplasms

NCT00887523 2022-12-20

Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis

University Hospital, Ghent

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms

NCT00887692 2010-10-19

Comparison of Set-up Reproducibility Between Prone and Supine Intensity Modulated Radiotherapy (IMRT) for the Adjuvant Treatment of Breast Carcinoma After Lumpectomy

University Hospital, Ghent

Phase NA Completed
10 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡